SCHEMBL2208577

SCHEMBL2208577

CCOC(=O)CCC(OCC)(OCC)OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
GAA P10253 2/20 0.46
MGAM O43451 1/20 0.46
SI P14410 1/20 0.46
MGAM2 Q2M2H8 1/20 0.46
ALDH1A1 P00352 5/20 0.43
TRPA1 O75762 1/20 0.43
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
NR1I2 O75469 1/20 0.38
PGR P06401 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
PTGS2 P35354 1/20 0.38
PDE4D Q08499 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LMNA P02545 2/20 0.37
HSD17B10 Q99714 2/20 0.37
POLB P06746 2/20 0.37
TSHR P16473 2/20 0.37
ALOX15 P16050 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11238402 0.84 CYP1A2 (0.50) CYP1A2GAAMGAMSIMGAM2
SCHEMBL187295 0.83 CYP1A2 (0.47) CYP1A2GAAMGAMSIMGAM2
SCHEMBL6650053 0.81 CYP1A2 (0.45) CYP1A2GAAMGAMSIMGAM2
SCHEMBL6329652 0.79 GAA (0.52) CYP1A2GAAMGAMSIMGAM2
SCHEMBL9705679 0.79 CYP1A2 (0.44) CYP1A2GAAMGAMSIMGAM2
SCHEMBL29035595 0.78 HDAC1 (0.32)
SCHEMBL407625 0.77 GAA (0.50) CYP1A2GAAMGAMSIMGAM2
SCHEMBL3368077 0.77 ALDH1A1 (0.52) CYP1A2GAAMGAMSIMGAM2
SCHEMBL28378490 0.77 GAA (0.50) CYP1A2GAAMGAMSIMGAM2
SCHEMBL28565057 0.77 ALDH1A1 (0.43) CYP1A2ALDH1A1LMNAHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981904-B2 Acetyl CoA carboxylase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-07-19 US disclosed
US-7981904-B2 Acetyl CoA carboxylase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-07-19 US disclosed
US-20090253725-A1 ACETYL CoA CARBOXYLASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-08 US disclosed
US-20090253725-A1 ACETYL CoA CARBOXYLASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253725-A1 ACETYL CoA CARBOXYLASE INHIBITORS ACACA, ACACB, ACAT1 CYP1A2 627/4885GAA 405/4885MGAM 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.